Gerald Grandl
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.
Journal: Nature
Published: April 19, 2025
Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism.
Journal: Molecular metabolism
Published: December 13, 2024
FGF21 reduces ER stress by enhancing the unfolded protein and integrated stress responses through increased sulfide signaling.
Journal: Cell metabolism
Published: December 05, 2024
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice.
Journal: Nature metabolism
Published: October 17, 2024
Why are we still in need for novel anti-obesity medications?
Journal: The Lancet regional health. Europe
Published: September 06, 2024
Recent achievements and future directions of anti-obesity medications.
Journal: The Lancet regional health. Europe
Published: August 07, 2024
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
Journal: Molecular metabolism
Published: December 14, 2023
Neuronal loss of TRPM8 leads to obesity and glucose intolerance in male mice.
Journal: Molecular metabolism
Published: January 20, 2023
Global, neuronal or β cell-specific deletion of inceptor improves glucose homeostasis in male mice with diet-induced obesity.
Journal: Nature metabolism
Published: March 28, 2022
Last Updated: 09/26/2026